LONDON (Reuters) - GlaxoSmithKline said on Friday it had withdrawn from the race to buy Pfizer's consumer healthcare business, which the U.S. drugmaker believes could be worth as much as $20 billion.

GSK pulls out of $20 billion race for Pfizer assets
Read More
Bagikan Berita Ini
0 Response to "GSK pulls out of $20 billion race for Pfizer assets"
Posting Komentar